Promotions & Moves

Biogen Appoints EVP, CCO

Merck veteran to lead commercial strategy

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Michel Vounatsos has been appointed executive vice president and chief commercial officer at Biogen, effective April 18, 2016.   Mr. Vounatsos will oversee the development and execution of Biogen’s global commercial strategy, with a focus on the company’s product portfolio and the development of the commercial infrastructure to support key pipeline assets. He will report to George Scangos, Ph.D., chief executive officer, and will be a member of the management team.   Mr. Vounatsos joins the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters